This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

ChinaBio® Partnering Forum
The Kerry Hotel
September 10–11, 2024 | Shanghai, ChinaSeptember 16–17, 2024 | Virtual

Gang Qin
Founder Chairman and CEO at GeneQuantum


Dr. Gang Qin owns nearly 20 years of research and management experience in renowned biomedical research institutions. He obtained PhD. in neurobiology from the University of Göttingen/Max-Planck Society, then worked at Max-Planck Institute of Biochemistry followed by Chinese Academy of Sciences. Dr. Qin has published series of original research papers in international scientific journals, also as major inventor he contributed more than 20 PCTs with some already granted globally.

Dr. Qin founded GeneQuantum Healthcare (Suzhou) Co., Ltd. in Suzhou, focusing on the development and production of new generation Bioconjugation Drugs which are represented by ADC. Led by Dr. Qin, GeneQuantum has successfully established world leading LDC technology and intelligent continuous conjugation platform. Facilitated by international and world class core management team with interdisciplinary nature, multiple innovative Bioconjugation Drugs with best-in-class or first-in-class potential are under development, addressing truly unmet medical need ultimately.

Agenda Sessions

  • Panel: CEO Perspective on the state of innovation in China - identifying the drivers, opportunities and challenges ahead.